These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 18981784)
1. Five years later: re-examining the financial burden of boosting with Norvir. Marquez C; Guglielmo BJ; Klausner JD AIDS; 2008 Nov; 22(17):2402-4. PubMed ID: 18981784 [No Abstract] [Full Text] [Related]
2. Drug pricing. Dismissal is denied in Norvir price-boosting suit. AIDS Policy Law; 2005 Nov; 20(21):6. PubMed ID: 16333878 [No Abstract] [Full Text] [Related]
3. FDA issues warning letter to Abbott over Norvir pricing spin. GMHC Treat Issues; 2004; 18(5-6):11. PubMed ID: 15359439 [No Abstract] [Full Text] [Related]
4. Abbott's Norvir price hike is bad medicine. Statement at the NIH public meeting on Norvir. Huff B GMHC Treat Issues; 2004; 18(5-6):10-2. PubMed ID: 15359438 [No Abstract] [Full Text] [Related]
11. Controversy over ritonavir price increase. AIDS Clin Care; 2004 Feb; 16(2):15. PubMed ID: 15032179 [No Abstract] [Full Text] [Related]
12. Drug pricing. AHF sues Abbott over drug price increase. AIDS Policy Law; 2004 Feb; 19(4):2. PubMed ID: 15045981 [No Abstract] [Full Text] [Related]
13. Backlash over ritonavir price hike. Huff B BETA; 2004; 16(4):15-7. PubMed ID: 15386839 [TBL] [Abstract][Full Text] [Related]
14. Open letter from ATAC to Abbott's CEO, Miles White. Dee L; Sharp M GMHC Treat Issues; 2003 Dec; 17(12):5. PubMed ID: 15011642 [No Abstract] [Full Text] [Related]
15. Intellectual property. NIH weighs demand to force sharing of AIDS drug patents. Malakoff D Science; 2004 Jun; 304(5676):1427-9. PubMed ID: 15178775 [No Abstract] [Full Text] [Related]